|
NIPAL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.242000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.843300E-03 |
| Normal-vs-Stage2 |
2.770600E-01 |
| Normal-vs-Stage3 |
2.465900E-02 |
| Normal-vs-Stage4 |
2.207200E-01 |
| Stage1-vs-Stage2 |
5.027000E-01 |
| Stage1-vs-Stage3 |
9.828600E-01 |
| Stage1-vs-Stage4 |
8.115600E-01 |
| Stage2-vs-Stage3 |
5.005800E-01 |
| Stage2-vs-Stage4 |
5.343800E-01 |
| Stage3-vs-Stage4 |
8.214800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.816700E-03 |
| Normal-vs-AfricanAmerican |
1.937510E-02 |
| Normal-vs-Asian |
6.152100E-02 |
| Caucasian-vs-AfricanAmerican |
9.463800E-01 |
| Caucasian-vs-Asian |
6.612800E-01 |
| AfricanAmerican-vs-Asian |
6.447400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.204000E-04 |
| Normal-vs-Female |
7.253800E-01 |
| Male-vs-Female |
3.120000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.492100E-02 |
| Normal-vs-Extreme_Weight |
6.28049999999991E-05 |
| Normal-vs-Obese |
1.613050E-01 |
| Normal-vs-Extreme_Obese |
2.980000E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.724800E-01 |
| Normal_Weight-vs-Obese |
6.297800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.899980E-01 |
| Extreme_Weight-vs-Obese |
1.938420E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.177400E-01 |
| Obese-vs-Extreme_Obese |
1.898440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.811380E-04 |
| Normal-vs-Age(41-60Yrs) |
3.570000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.014100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.835500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.776100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.959700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.416800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.406400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.124200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.210600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.213500E-04 |
| Normal-VS-Type2 PRCC |
2.679200E-01 |
| Normal-VS-KIRP CIMP |
5.22190000018519E-07 |
| Normal-VS-Unclassified PRCC |
9.538800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.437800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.566000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.337200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.94530000008753E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.463200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.64730000002034E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.297800E-03 |
| Normal-vs-N1 |
8.413700E-02 |
| Normal-vs-N2 |
1.128780E-01 |
| N0-vs-N1 |
5.783600E-01 |
| N0-vs-N2 |
9.599400E-01 |
| N1-vs-N2 |
7.897000E-01 |
|
|
